1. Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin. (1st January 2021) Authors: Milentijevic, Dejan; Lin, Jennifer H.; Chen, Yen-Wen; Kogan, Emily; Shrivastava, Shubham; Sjoeland, Erik; Alberts, Mark Journal: Journal of medical economics Issue: Volume 24:Number 1(2021) Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗